Screening and deciphering antibiotic resistance in Acinetobacter baumannii: A state of the art

Expert Review of Anti-Infective Therapy

Volumn 11, Issue 6, 2013, Pages 571-583

  Bonnin, Rémy A ^a   Nordmann, Patrice ^a   Poirel, Laurent ^a  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

Author keywords

lactamases; Acinetobacter baumannii; carbapenemase; detection; resistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; COLISTIN; DORIPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULBACTAM; TETRACYCLINE; TICARCILLIN; TIGECYCLINE; TIMENTIN; TOBRAMYCIN; UNINDEXED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; EARLY DIAGNOSIS; GENE DISRUPTION; GENE OVEREXPRESSION; HORIZONTAL GENE TRANSFER; LABORATORY TEST; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; SCREENING;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CEPHALOSPORINS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION; GENE TRANSFER, HORIZONTAL; HUMANS; MINOCYCLINE; MUTATION;

EID: 84878831614     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.13.38     Document Type: Review

References (100)

1. Bou G, Martínez-Beltrán J. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC ?-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44(2), 428-432 (2000).
2. Corvec S, Caroff N, Espaze E, Giraudeau C, Drugeon H, Reynaud A. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J. Antimicrob. Chemother. 52(4), 629-635 (2003).
3. Héritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12(2), 123-130 (2006).
4. Rodríguez-Martínez JM, Nordmann P, Ronco E, Poirel L. Extended-spectrum cephalosporinase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54(8), 3484-3488 (2010).
5. Tian GB, Adams-Haduch JM, Taracila M, Bonomo RA, Wang HN, Doi Y. Extendedspectrum AmpC cephalosporinase in Acinetobacter baumannii: ADC-56 confers resistance to cefepime. Antimicrob. Agents Chemother. 55(10), 4922-4925 (2011).
6. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D ?-lactamases. Antimicrob. Agents Chemother. 54(1), 24-38 (2010).
7. Figueiredo S, Poirel L, Croize J, Recule C, Nordmann P. In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural blaOXA-66 oxacillinase gene. Antimicrob. Agents Chemother. 53(6), 2657-2659 (2009).
8. Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P. Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9. Antimicrob. Agents Chemother. 53(9), 4045-4047 (2009).
9. Turton JF, Ward ME, Woodford N et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258(1), 72-77 (2006).
10. Poirel L, Bonnin RA, Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 63(12), 1061-1067 (2011).
11. Zhao WH, Hu ZQ. Acinetobacter: a potential reservoir and dispenser for ?-lactamases. Crit. Rev. Microbiol. 38(1), 30-51 (2012).
12. Poirel L, Cabanne L, Vahaboglu H, Nordmann P. Genetic environment and expression of the extended-spectrum ?-lactamase blaPER-1 gene in Gram-negative bacteria. Antimicrob. Agents Chemother. 49(5), 1708-1713 (2005).
13. Bonnin RA, Potron A, Poirel L, Lecuyer H, Neri R, Nordmann P. PER-7, an extendedspectrum ?-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55(5), 2424-2427 (2011).
14. Pasterán F, Rapoport M, Petroni A et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob. Agents Chemother. 50(9), 3222-3224 (2006).
15. Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum ?-lactamases in Acinetobacter baumannii in Belgium. J. Antimicrob. Chemother. 58(1), 178-182 (2006).
16. Naas T, Coignard B, Carbonne A et al.; French Nosocomial Infection Early Warning Investigation and Surveillance Network. VEB-1 Extended-spectrum ?-lactamase-producing Acinetobacter baumannii, France. Emerging Infect. Dis. 12(8), 1214-1222 (2006).
17. Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum ?-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43(3), 573-581 (1999).
18. Huang LY, Chen TL, Lu PL et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin. Microbiol. Infect. 14(11), 1010-1019 (2008).
19. Poirel L, Corvec S, Rapoport M et al. Identification of the novel narrow-spectrum ?-lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrob. Agents Chemother. 51(6), 2179-2184 (2007).
20. Poirel L, Bonnin RA, Nordmann P. Genetic support and diversity of acquired extended-spectrum ?-lactamases in Gram-negative rods. Infect. Genet. Evol. 12(5), 883-893 (2012).
21. Bogaerts P, Naas T, El Garch F et al. GES extended-spectrum ?-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob. Agents Chemother. 54(11), 4872-4878 (2010).
22. Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L. Carbapenem-hydrolyzing GES-type extended-spectrum ?-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55(1), 349-354 (2011).
23. Adams-Haduch JM, Paterson DL, Sidjabat HE et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob. Agents Chemother. 52(11), 3837-3843 (2008).
24. Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. Spread of blaCTX-M-type and blaPER-2 ?-lactamase genes in clinical isolates from Bolivian hospitals. J. Antimicrob. Chemother. 57(5), 975-978 (2006).
25. Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y. Nosocomial transmission of CTX-M-2 ?-lactamaseproducing Acinetobacter baumannii in a neurosurgery ward. J. Clin. Microbiol. 42(9), 3978-3984 (2004).
26. Potron A, Munoz-Price LS, Nordmann P, Cleary T, Poirel L. Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti. Antimicrob. Agents Chemother. 55(12), 5946-5948 (2011).
27. Héritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49(8), 3198-3202 (2005).
28. Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerging Infect. Dis. 16(1), 35-40 (2010).
29. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21(3), 538-582 (2008).
30. Bogaerts P, Cuzon G, Naas T et al. Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium. Antimicrob. Agents Chemother. 52(11), 4205-4206 (2008).
31. Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in baumannii. Antimicrob. Agents Chemother. 51(4), 1530-1533 (2007).
32. Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob. Agents Chemother. 52(4), 1252-1256 (2008).
33. Higgins PG, Schneiders T, Hamprecht A, Seifert H. In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrob. Agents Chemother. 54(12), 5021-5027 (2010).
34. Nemec A, Krizova L, Maixnerova M et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162(4), 393-404 (2011).
35. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. OXA-143, a novel carbapenem-hydrolyzing class D ?-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53(12), 5035-5038 (2009).
36. Mostachio AK, Levin AS, Rizek C, Rossi F, Zerbini J, Costa SF. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil. Int. J. Antimicrob. Agents 39(5), 396-401 (2012).
37. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-?-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18(2), 306-325 (2005).
38. Bonnin RA, Poirel L, Naas T et al. Dissemination of New Delhi metallo-?-lactamase-1-producing Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 18(9), E362-E365 (2012).
39. Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66(6), 1260-1262 (2011).
40. Poirel L, Bonnin RA, Nordmann P. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob. Agents Chemother. 55(9), 4224-4229 (2011).
41. Poirel L, Bonnin RA, Boulanger A, Schrenzel J, Kaase M, Nordmann P. Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii. Antimicrob. Agents Chemother. 56(2), 1087-1089 (2012).
42. Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 66(6), 1255-1259 (2011).
43. Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65(10), 2253-2254 (2010).
44. Robledo IE, Aquino EE, Vázquez GJ. Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob. Agents Chemother. 55(6), 2968-2970 (2011).
45. Bonnin RA, Rotimi VO, Al Hubail M et al. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob. Agents Chemother. 57(1), 183-188 (2013).
46. Moubareck C, Brémont S, Conroy MC, Courvalin P, Lambert T. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53(8), 3579-3581 (2009).
47. Cayô R, Rodríguez MC, Espinal P et al. Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 55(12), 5907-5913 (2011).
48. Coyne S, Courvalin P, Périchon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 55(3), 947-953 (2011).
49. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J. Clin. Microbiol. 49(2), 718-721 (2011).
50. Bonnin RA, Naas T, Poirel L, Nordmann P. Phenotypic, biochemical, and molecular techniques for detection of metallo-?-lactamase NDM in Acinetobacter baumannii. J. Clin. Microbiol. 50(4), 1419-1421 (2012).
51. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-?-lactamase-producing Gramnegative bacilli in the clinical laboratory. J. Clin. Microbiol. 44(9), 3139-3144 (2006).
52. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-?-lactamaseproducing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41(10), 4623-4629 (2003).
53. Kempf M, Rolain JM, Diatta G et al. Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs. PLoS ONE 7(6), e39495 (2012).
54. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important ?-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65(3), 490-495 (2010).
55. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70(1), 119-123 (2011).
56. Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J. Antimicrob. Chemother. 67(4), 906-909 (2012).
57. Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum ?-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J. Clin. Microbiol. 49(4), 1608-1613 (2011).
58. Dortet L, Poirel L, Nordmann P. Rapid detection of carbapenemase- producing Pseudomonas spp. J. Clin. Microbiol. 50(11), 3773-3776 (2012).
59. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase- producing Enterobacteriaceae. Emerging Infect. Dis. 18(9), 1503-1507 (2012).
60. Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J. Antimicrob. Chemother. 56(3), 463-469 (2005).
61. Vila J, Martí S, Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 59(6), 1210-1215 (2007).
62. Galimand M, Courvalin P, Lambert T. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob. Agents Chemother. 47(8), 2565-2571 (2003).
63. Yamane K, Wachino J, Doi Y, Kurokawa H, Arakawa Y. Global spread of multiple aminoglycoside resistance genes. Emerging Infect. Dis. 11(6), 951-953 (2005).
64. Berçot B, Poirel L, Nordmann P. Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers. Diagn. Microbiol. Infect. Dis. 71(4), 442-445 (2011).
65. Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45(1), 88-94 (2007).
66. Tupin A, Gualtieri M, Roquet-Banères F, Morichaud Z, Brodolin K, Leonetti JP. Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. Int. J. Antimicrob. Agents 35(6), 519-523 (2010).
67. Giannouli M, Di Popolo A, Durante?Mangoni E et al. Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy. Int. J. Antimicrob. Agents 39(1), 58-63 (2012).
68. Fournier PE, Vallenet D, Barbe V et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2(1), e7 (2006).
69. Speer BS, Shoemaker NB, Salyers AA. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin. Microbiol. Rev. 5(4), 387-399 (1992).
70. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51(10), 3471-3484 (2007).
71. Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J. Clin. Microbiol. 45(1), 227-230 (2007).
72. Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin. Microbiol. Rev. 21(3), 449-465 (2008).
73. Adams MD, Nickel GC, Bajaksouzian S et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the pmrAB two-component system. Antimicrob. Agents Chemother. 53(9), 3628-3634 (2009).
74. Cai Y, Chai D, Wang R et al. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J. Antimicrob. Chemother. 67(7), 1607-1615 (2012).
75. Moffatt JH, Harper M, Adler B et al. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55(6), 3022-3024 (2011).
76. Moffatt JH, Harper M, Harrison P et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54(12), 4971-4977 (2010).
77. Li J, Rayner CR, Nation RL et al. Heteroresistance to colistin in multidrugresistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50(9), 2946-2950 (2006).
78. Doi Y, Onuoha EO, Adams-Haduch JM et al. Screening for Acinetobacter baumannii colonization by use of sponges. J. Clin. Microbiol. 49(1), 154-158 (2011).
79. Wareham DW, Gordon NC. Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii. J. Clin. Pathol. 64(2), 164-167 (2011).
80. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9(2), 148-165 (1996).
81. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N. Engl. J. Med. 358(12), 1271-1281 (2008).
82. Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin. Infect. Dis. 51(1), 79-84 (2010).
83. Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J. Hosp. Infect. 73(2), 143-150 (2009).
84. Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii. Am. J. Infect. Control 30(7), 386-390 (2002).
85. Marques MB, Brookings ES, Moser SA, Sonke PB, Waites KB. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations. Antimicrob. Agents Chemother. 41(5), 881-885 (1997).
86. Freney J, Renaud F, Leclercq R, Riegel P. Précis de Bactériologie Clinique (2nd Edition). Editions ESKA, Paris, France, 959-978 (2007).
87. López-Rojas R, Docobo-Pérez F, Pachón? Ibáñez ME et al. Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 30(11), 1391-1398 (2011).
88. Yang H, Liang L, Lin S, Jia S. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol. 10, 131 (2010).
89. García-Quintanilla M, Pulido MR, López-Rojas R, Pachón J, McConnell MJ. Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol. 21(3), 157-163 (2013).
90. Vallenet D, Nordmann P, Barbe V et al. Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS ONE 3(3), e1805 (2008).
91. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35(5), 736-755 (2011).
92. Paavilainen T, Alanen M, Mäkelä M et al. Infrequent isolation of multiresistant Acinetobacter baumannii from the staff tending a colonized patient with severe burns. Infect. Control Hosp. Epidemiol. 22(6), 388-391 (2001).
93. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin. Microbiol. Infect. 11(11), 868-873 (2005).
94. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol. Med. 18(5), 263-272 (2012).
95. Bonnin RA, Poirel L, Benoit-Cattin T, Nordmann P. Ceftazidime-susceptible and imipenem-non-susceptible OXA-58-producing Acinetobacter baumannii from the Comoros archipelago. Int. J. Antimicrob. Agents 41(3), 297-298 (2013).
96. Bernabeu S, Poirel L, Nordmann P. Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 74(1), 88-90 (2012).
97. Poirel L, Dortet L, Bernabeu S, Nordmann P. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob. Agents Chemother. 55(11), 5403-5407 (2011).
98. Mendes RE, Kiyota KA, Monteiro J et al. Rapid detection and identification of metallo-?-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J. Clin. Microbiol. 45(2), 544-547 (2007).
99. Figueiredo S, Bonnin RA, Poirel L, Duranteau J, Nordmann P. Identification of the naturally occurring genes encoding carbapenem-hydrolysing oxacillinases from Acinetobacter haemolyticus, Acinetobacter johnsonii, and Acinetobacter calcoaceticus. Clin. Microbiol. Infect. 18(9), 907-913 (2012).
100. Kulah C, Aktas E, Comert F, Ozlu N, Akyar I, Ankarali H. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway. BMC Infect. Dis. 16(9), 30 (2009).